Command Palette

Search for a command to run...

BLUEJET
663.85(-2.06%)
1W: +7.56%

Blue Jet Healthcare Peer Comparison

Snapshot Summary

Blue Jet Healthcare Ltd. stands out as a growth outperformer with the highest ROE in its peer group, showcasing impressive profitability metrics. While it has a high PE ratio, its strong earnings growth potential justifies this valuation. In contrast, several peers exhibit weaker growth, higher valuations, or financially risky profiles, making Blue Jet a compelling investment choice in the Pharmaceuticals & Drugs sector.

  • Blue Jet has the highest ROE (51.06%) among its peers, indicating strong profitability.
  • Several peers exhibit high PE ratios with limited growth, suggesting potential overvaluation.
  • Financially weak companies in the sector have low margins and high debt levels, highlighting risk.
  • Blue Jet Healthcare Ltd.: Highest ROE (51.06%) and strong earnings potential.
  • Cipla Ltd.: Strong profitability metrics with a low PE ratio (23.73) relative to its growth.
  • Dr. Reddy's Laboratories Ltd.: Solid growth trajectory with a low PE ratio (15.50) and good ROE.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
BLUEJET₹651.05₹11,293.44Cr31.4956.68%0.15
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.